Boehringer Ingelheim
Holly Colbert, CPA, MBA, has extensive experience in finance and strategic operations within the pharmaceutical and nonprofit sectors. Since October 2011, Holly has held various leadership roles at Boehringer Ingelheim, currently serving as Executive Director of Analytics & Insights, after previously being the Chief of Staff to the President of Human Pharmaceuticals. Prior to this, Holly worked at The Leukemia & Lymphoma Society from February 2003 to October 2011, progressing to the role of Controller. Holly's career began at Arthur Andersen & Co. as an Auditor, followed by a position as Assistant Manager of Financial Reporting at TBWA\Worldwide. Academically, Holly earned a BS in Accounting from the University at Buffalo and an MBA from Western Connecticut State University.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.